Highlights The HPV vaccine is crucial in cervical cancer prevention as it can provide ~10 to 100-fold higher antibody titers than natural infection. 1 Patient and parent counseling is essential to strengthen the vaccination uptake.
This article aims to cover the progress, current status, as well as future outlook of vaccines in the pipeline to prevent and treat HPV-associated lesions and cancers and accordingly lay down the base for new original vaccine development. 2
